FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035812199> ?p ?o ?g. }

• W2035812199 endingPage "138" @default.
• W2035812199 startingPage "131" @default.
• W2035812199 abstract "Giant cell carcinoma of the lung (GCCL) is an uncommon and extremely aggressive variant of lung cancer. Characteristic microscopic findings include marked pleomorphism, aggregates of mononucleated or multinucleated giant cells (or both), a general lack of architectural cohesiveness, extensive necrosis, and endocytosis by the giant cells. Although the epithelial character of GCCL has been confirmed by a number of studies, controversy persists as to whether it represents a variant of poorly differentiated adenocarcinoma or of squamous carcinoma. Histochemical studies for mucosubstances have yielded variable and conflicting results. This report describes conventionally fixed and processed samples from 10 cases of GCCL studied with a panel of monoclonal antibodies (Mabs) recognizing different cytokeratin polypeptides (AE1, AE3, AE1/AE3 cocktail, and CAM 5.2), vimentin, and Mab A-80, the last of which binds to a mucinous glycoprotein associated with exocrine differentiation. All 10 cases of GCCL reacted with all cytokeratin Mabs; the extent and intensity of the reaction varied notably. All cases stained strongly and diffusely with Mab AE1 and AE1/AE3, the reaction was less extensive and weaker with CAM 5.2. Significantly, 2 cases reacted focally with Mab AE3. Nine cases reacted extensively and intensely with the vimentin Mab, often showing prominent paranuclear globular profiles. All cases reacted with Mab A-80; the reaction was often strong, but the extent was variable. Findings indicate that all GCCL are indeed cytokeratin positive but that most express polypeptides toward the low-molecular weight end of the spectrum; a small subset also expresses heavier polypeptides. This profile suggests that all GCCL display cytokeratins characteristic of adenocarcinoma but that a subset also shows polypeptides typical of squamous carcinomas; significantly, all GCCL retained their exocrine phenotype as defined by their positivity with Mab A-80. Moreover, the consistent if not invariable finding of vimentin positivity adds to an immunohistochemical profile that is distinct from that of the vast majority of lung cancers." @default.
• W2035812199 created "2016-06-24" @default.
• W2035812199 creator A5001990005 @default.
• W2035812199 creator A5004614086 @default.
• W2035812199 creator A5022186287 @default.
• W2035812199 creator A5030183042 @default.
• W2035812199 creator A5030695736 @default.
• W2035812199 creator A5040366534 @default.
• W2035812199 creator A5056811989 @default.
• W2035812199 creator A5083485335 @default.
• W2035812199 creator A5087539286 @default.
• W2035812199 date "1991-01-01" @default.
• W2035812199 modified "2023-10-18" @default.
• W2035812199 title "Immunohistochemical Features of Giant Cell Carcinoma of the Lung: Patterns of Expression of Cytokeratins, Vimentin, and the Mucinous Glycoprotein Recognized by Monoclonal Antibody A-80" @default.
• W2035812199 cites W121222821 @default.
• W2035812199 cites W168537938 @default.
• W2035812199 cites W1966604985 @default.
• W2035812199 cites W1969007097 @default.
• W2035812199 cites W1971784584 @default.
• W2035812199 cites W1976453471 @default.
• W2035812199 cites W1976731340 @default.
• W2035812199 cites W1983542372 @default.
• W2035812199 cites W1998950810 @default.
• W2035812199 cites W2003626812 @default.
• W2035812199 cites W2019723261 @default.
• W2035812199 cites W2020762781 @default.
• W2035812199 cites W2030670671 @default.
• W2035812199 cites W2031973934 @default.
• W2035812199 cites W2040745517 @default.
• W2035812199 cites W2056021664 @default.
• W2035812199 cites W2061109470 @default.
• W2035812199 cites W2064954805 @default.
• W2035812199 cites W2073705753 @default.
• W2035812199 cites W2075826490 @default.
• W2035812199 cites W2092240129 @default.
• W2035812199 cites W2094227775 @default.
• W2035812199 cites W2114690717 @default.
• W2035812199 cites W2143997541 @default.
• W2035812199 cites W2316170398 @default.
• W2035812199 cites W2398103039 @default.
• W2035812199 cites W1991141176 @default.
• W2035812199 doi "https://doi.org/10.3109/01913129109016231" @default.
• W2035812199 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1710080" @default.
• W2035812199 hasPublicationYear "1991" @default.
• W2035812199 type Work @default.
• W2035812199 sameAs 2035812199 @default.
• W2035812199 citedByCount "20" @default.
• W2035812199 countsByYear W20358121992014 @default.
• W2035812199 countsByYear W20358121992015 @default.
• W2035812199 countsByYear W20358121992019 @default.
• W2035812199 countsByYear W20358121992023 @default.
• W2035812199 crossrefType "journal-article" @default.
• W2035812199 hasAuthorship W2035812199A5001990005 @default.
• W2035812199 hasAuthorship W2035812199A5004614086 @default.
• W2035812199 hasAuthorship W2035812199A5022186287 @default.
• W2035812199 hasAuthorship W2035812199A5030183042 @default.
• W2035812199 hasAuthorship W2035812199A5030695736 @default.
• W2035812199 hasAuthorship W2035812199A5040366534 @default.
• W2035812199 hasAuthorship W2035812199A5056811989 @default.
• W2035812199 hasAuthorship W2035812199A5083485335 @default.
• W2035812199 hasAuthorship W2035812199A5087539286 @default.
• W2035812199 hasConcept C121608353 @default.
• W2035812199 hasConcept C142160229 @default.
• W2035812199 hasConcept C142724271 @default.
• W2035812199 hasConcept C147447768 @default.
• W2035812199 hasConcept C153911025 @default.
• W2035812199 hasConcept C159654299 @default.
• W2035812199 hasConcept C203014093 @default.
• W2035812199 hasConcept C204232928 @default.
• W2035812199 hasConcept C2779012181 @default.
• W2035812199 hasConcept C2781182431 @default.
• W2035812199 hasConcept C542903549 @default.
• W2035812199 hasConcept C54355233 @default.
• W2035812199 hasConcept C71924100 @default.
• W2035812199 hasConcept C77076574 @default.
• W2035812199 hasConcept C86803240 @default.
• W2035812199 hasConceptScore W2035812199C121608353 @default.
• W2035812199 hasConceptScore W2035812199C142160229 @default.
• W2035812199 hasConceptScore W2035812199C142724271 @default.
• W2035812199 hasConceptScore W2035812199C147447768 @default.
• W2035812199 hasConceptScore W2035812199C153911025 @default.
• W2035812199 hasConceptScore W2035812199C159654299 @default.
• W2035812199 hasConceptScore W2035812199C203014093 @default.
• W2035812199 hasConceptScore W2035812199C204232928 @default.
• W2035812199 hasConceptScore W2035812199C2779012181 @default.
• W2035812199 hasConceptScore W2035812199C2781182431 @default.
• W2035812199 hasConceptScore W2035812199C542903549 @default.
• W2035812199 hasConceptScore W2035812199C54355233 @default.
• W2035812199 hasConceptScore W2035812199C71924100 @default.
• W2035812199 hasConceptScore W2035812199C77076574 @default.
• W2035812199 hasConceptScore W2035812199C86803240 @default.
• W2035812199 hasIssue "2" @default.
• W2035812199 hasLocation W20358121991 @default.
• W2035812199 hasLocation W20358121992 @default.
• W2035812199 hasOpenAccess W2035812199 @default.
• W2035812199 hasPrimaryLocation W20358121991 @default.
• W2035812199 hasRelatedWork W150275630 @default.
• W2035812199 hasRelatedWork W1989845789 @default.

• next